DE602006014379D1 - Neurodegenerative marker für depression. - Google Patents

Neurodegenerative marker für depression.

Info

Publication number
DE602006014379D1
DE602006014379D1 DE602006014379T DE602006014379T DE602006014379D1 DE 602006014379 D1 DE602006014379 D1 DE 602006014379D1 DE 602006014379 T DE602006014379 T DE 602006014379T DE 602006014379 T DE602006014379 T DE 602006014379T DE 602006014379 D1 DE602006014379 D1 DE 602006014379D1
Authority
DE
Germany
Prior art keywords
depression
markers
disease
values
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006014379T
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
Norbert Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Antwerpen
Klinik und Poliklinik fur Psychiatrie und Psychotherapie
Universiteit Maastricht
Original Assignee
Universiteit Antwerpen
Klinik und Poliklinik fur Psychiatrie und Psychotherapie
Universiteit Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Antwerpen, Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Universiteit Maastricht filed Critical Universiteit Antwerpen
Publication of DE602006014379D1 publication Critical patent/DE602006014379D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
DE602006014379T 2005-04-06 2006-03-30 Neurodegenerative marker für depression. Active DE602006014379D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions

Publications (1)

Publication Number Publication Date
DE602006014379D1 true DE602006014379D1 (de) 2010-07-01

Family

ID=36293430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014379T Active DE602006014379D1 (de) 2005-04-06 2006-03-30 Neurodegenerative marker für depression.

Country Status (14)

Country Link
US (2) US20080131921A1 (de)
EP (2) EP1866650B1 (de)
JP (1) JP4958893B2 (de)
AT (2) ATE534038T1 (de)
CY (1) CY1110116T1 (de)
DE (1) DE602006014379D1 (de)
DK (2) DK1866650T3 (de)
ES (2) ES2377704T3 (de)
HK (1) HK1137219A1 (de)
NO (2) NO20075671L (de)
PL (2) PL2146209T3 (de)
PT (2) PT1866650E (de)
SI (1) SI1866650T1 (de)
WO (1) WO2006105907A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053405A4 (de) * 2006-08-04 2009-11-11 Ajinomoto Kk Verfahren zur bewertung von stress, stressbewertungsvorrichtung, stressbewertungsverfahren, stressbewertungssystem, stressbewertungsprogramm und aufzeichnungsmedium
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
ES2663662T3 (es) 2008-01-18 2018-04-16 President And Fellows Of Harvard College Métodos para detectar distintivos de enfermedades o afecciones en fluidos corporales
JP5410997B2 (ja) * 2008-01-31 2014-02-05 則行 川村 うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
CN104777314B (zh) 2009-08-12 2017-01-04 福满代谢组技术有限公司 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
CN110846405A (zh) 2010-07-23 2020-02-28 哈佛大学校长及研究员协会 用于检测体液中的疾病或病症标记的方法
SG187582A1 (en) 2010-07-23 2013-03-28 Harvard College Methods of detecting diseases or conditions using phagocytic cells
EP2596116A4 (de) 2010-07-23 2014-03-19 Harvard College Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
JP5688163B2 (ja) 2011-11-10 2015-03-25 ヒューマン・メタボローム・テクノロジーズ株式会社 エタノールアミンリン酸の測定方法
EA201590027A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы детекции заболеваний или состояний
BR112014031414A2 (pt) 2012-06-15 2017-06-27 Stylli Harry métodos de detectar doenças ou condições utilizando células doentes circulantes
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
EP2965086A4 (de) 2013-03-09 2017-02-08 Harry Stylli Verfahren zum nachweis von prostatakrebs
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2799878A1 (de) * 2013-05-03 2014-11-05 SALION GmbH In vitro Verfahren zur Früherkennung von potenziellen Entzündungen, insbesondere im Zusammenhang mit der Abstoßung eines Transplantats
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
EP4428251A2 (de) 2014-09-11 2024-09-11 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
US11806385B2 (en) 2016-04-22 2023-11-07 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (de) * 2017-06-08 2018-12-12 SALION GmbH In vitro verfahren zur erkennung neurodegenerativer erkrankungen
US11079329B2 (en) * 2017-09-27 2021-08-03 University of North Carolina Wilmington Human waste water and human-derived pathogen scouting tool
KR102699211B1 (ko) 2018-03-19 2024-08-26 후지필름 가부시키가이샤 정신 질환의 판정 방법
CN114177366A (zh) * 2018-03-22 2022-03-15 株式会社日本医疗机器技研 生物可吸收支架
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
JP7389139B2 (ja) * 2019-11-26 2023-11-29 京セラ株式会社 ストレス計測システムおよびストレス計測方法
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (de) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methoden zur Diagnostizierung oder zur Behandlung von neuropsychiatrischen Erkrankungen, die auf erhöhten Neurotrophin 3-Spiegel basiert sind
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
US20120196300A1 (en) 2012-08-02
DK2146209T3 (da) 2012-02-13
ES2346467T3 (es) 2010-10-15
PT1866650E (pt) 2010-06-01
CY1110116T1 (el) 2015-01-14
EP1866650B1 (de) 2010-05-19
PT2146209E (pt) 2011-12-30
PL1866650T3 (pl) 2011-04-29
HK1137219A1 (en) 2010-07-23
WO2006105907A1 (en) 2006-10-12
SI1866650T1 (sl) 2010-12-31
ATE534038T1 (de) 2011-12-15
US20080131921A1 (en) 2008-06-05
EP2146209A1 (de) 2010-01-20
JP2008537111A (ja) 2008-09-11
NO20120452L (no) 2007-11-06
PL2146209T3 (pl) 2012-05-31
NO20075671L (no) 2007-11-06
EP1866650A1 (de) 2007-12-19
ATE468537T1 (de) 2010-06-15
JP4958893B2 (ja) 2012-06-20
DK1866650T3 (da) 2010-09-06
ES2377704T3 (es) 2012-03-30
EP2146209B1 (de) 2011-11-16

Similar Documents

Publication Publication Date Title
ATE468537T1 (de) Neurodegenerative marker für depression.
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
AR054479A1 (es) Metodo para diagnosticar l a enfermedad de alzheimer
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
CY1112737T1 (el) Ισοτοπικα σεσημασμενες ενωσεις βενζοfuran σαν παραγοντες απεικονισης για πρωτεϊνες δημιουργιας αμυλοειδους (αμυloid)
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
EP1700096A4 (de) Nachweis von proteinen und prionen mit veränderter konformation
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DE502004009577D1 (de) Vorrichtung zur bestimmung eines drehpunkts eines fahrzeugs um eine fahrzeughochachse
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
ATE414904T1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo
ATE530548T1 (de) Neue dibenzoäc,hüä1,5ü naphthyridine und ihre verwendung als dna-sonden
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
ATE442084T1 (de) Messung des energieverbrauchs
EP1907838A4 (de) Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer
WO2008148492A8 (en) Neurofilamental proteins as biomarker for alzheimer's disease
DE60314258D1 (de) Gtp cyclohydrolase ii als ziel für fungizide
WO2008148493A3 (en) Annexin a5 and annexin a6 as biomarkter for alzheimer's disease
FR2869835B3 (fr) Instrument d'ecriture indiquant l'heure
UA11937S (uk) Кашкет чоловічий формений
UA11938S (uk) Кашкет чоловічий формений

Legal Events

Date Code Title Description
8364 No opposition during term of opposition